MedPath

Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

Phase 4
Completed
Conditions
Post Menopausal Dry Eye Subjects
Interventions
Other: Systane Ultra Lubricant Eye Drops
Other: Sensitive Eyes Eye Drops (Bausch & Lomb)
Registration Number
NCT01105910
Lead Sponsor
Alcon Research
Brief Summary

To evaluate the efficacy of Systane Ultra in post menopausal women with dry eye.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  1. Post-menopausal (menses ceased more than 12 months prior to the start of the study).
  2. Diagnosed for dry eye
Read More
Exclusion Criteria
  1. History of Sjögren's Syndrome or evidence of chronic dry eye syndrome. Confirmed autoimmune connective tissue diseases such as rheumatoid arthritis, fibromyalgia or scleroderma.
  2. Active and severe blepharitis, rosacea and associated ocular sequelae.
  3. Has any significant eyelid abnormality affecting lid function.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Systane UltraSystane Ultra Lubricant Eye DropsSystane Ultra Lubricant Eye Drops
Sensitive EyesSensitive Eyes Eye Drops (Bausch & Lomb)Sensitive Eyes Eye Drops (Bausch \& Lomb)
Primary Outcome Measures
NameTimeMethod
Reduction in corneal staining30 days
Secondary Outcome Measures
NameTimeMethod
Patient acceptability / comfort30 days
© Copyright 2025. All Rights Reserved by MedPath